Pursuant to subsection D of § 54.1-3443, the Board of Pharmacy is giving notice of a public hearing to consider placement of chemical substances in Schedule I of the Drug Control Act. The public hearing will be conducted at 9:00 a.m. on March 26, 2019 at the Perimeter Center, 9960 Mayland Drive, Suite 201, Richmond, VA 23233. Public comment may also be submitted electronically or in writing prior to March 12, 2019 to Caroline Juran, Executive Director of the Board of Pharmacy to caroline.juran@dhp.virginia.gov.
Pursuant to article § 54.1-3443(D), The Virginia Department of Forensic Science (DFS) has identified three (3) compounds for recommended inclusion into the Code of Virginia. The following is a brief description, chemical name, and common name for each compound.
The following compound is classified as powerful synthetic opioid. Compounds of this type have been placed in Schedule I (§ 54.1-3446(1)) in previous legislative sessions.
The following compounds are classified as research chemicals. Compounds of this type have been placed in Schedule I (§ 54.1-3446(3)) in previous legislative sessions.
Name / Title: | Caroline Juran, RPh / Executive Director |
Address: |
9960 Mayland Drive Suite 300 Richmond, 23233 |
Email Address: | caroline.juran@dhp.virginia.gov |
Telephone: | (804)367-4456 FAX: (804)527-4472 TDD: ()- |